BioZone

What BioZone does

BioZone is a PhD training program at The University of Western Australia (UWA), headquartered in Perth, Australia. Founded in 2014 and celebrating its 10th anniversary on 24 September 2024, the program convenes researchers from UWA's Schools of Engineering, Biological, Biomedical, Molecular, and Human Sciences to pursue transdisciplinary biomedical research. It serves early-stage PhD candidates admitted through UWA pathways, offering customized candidacy milestones, a 12-month proposal timeline (versus the standard 6 months), collaboration grants requiring at least two principal investigators, and completion scholarships that extend stipends to the full four-year PhD duration. As of the source data, BioZone lists approximately 15 current PhD students across multiple impact areas and 13 faculty researchers, with 9 documented alumni.

BioZone does not produce commercial products or generate revenue from goods or services; its outputs are programmatic. Funding for scholarships and grants flows through an anonymous philanthropic partner. The program operates in partnership with the Harry Perkins Institute of Medical Research (which houses BRITElab, T3mPLATE laboratory, and Choi Lab), Perth Biodesign, the WA Biomedical Engineering Society, the WA Life Sciences Innovation Hub, two ARC Centres of Excellence (Therapeutics Technologies, Biomedical Analysis), and the Perron Institute for Neurological and Translational Science. Research impact areas include cancer, neurogenetic diseases, heart disease and stroke, kidney disease, and mental health, with featured projects spanning the FOCUST fluorescence segmentation toolbox, novel biomaterials, soft robotics, 3D granular hydrogels, stem cell bioengineering, and rTMS.

BioZone is not a commercial entity and has no funding rounds, pricing model, or investable securities. The program's leadership overlaps with adjacent biomedical initiatives — Prof Kevin Pfleger chairs Perth Biodesign and Biodesign Australia, serves as Chief Scientific Advisor of ASX-listed Dimerix and is connected to RAGE Biotech and VeinTech; A/Prof Elena De-Juan-Pardo co-founded CoraMetix Pty Ltd. These linkages position BioZone as a talent and translational amplifier within Western Australia's biomedical ecosystem rather than as an independent business.

Name

BioZone

Legal name

WA BioZone

Website

https://wabiozone.au

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

BioZone is a non-commercial PhD training program at the University of Western Australia, founded in 2014 in Perth. It equips early-stage biomedical PhD candidates with extended candidacy timelines, collaboration grants, scholarships, and transdisciplinary mentorship across UWA's engineering and science schools.

Ownership category

akta.pro rank

Product category

Biomedical Research Training

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Educational Services (8200), Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYEDAHAGAI

Biomedical Sciences & Medical Research Institutes (University-Based)

Education/Higher Education (Colleges & Universities)/Medical & Health Sciences Universities

SECONDARYEDAIAIAF

Research & Lab-Based Short-Term Programs (Undergraduate/Graduate)

Education/International Education & Study Abroad/International Summer/Winter Schools & Short-Term Academic Programs

SECONDARYHLAIALAF

Translational Medicine & Biomarkers

Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development

Keywords

• Biomedical research training
• PhD training program
• Transdisciplinary research
• Biomedical engineering
• Research collaboration

Headquarters

HQ city

Perth

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Others

Marketing channels3 records

Core offering

BioZone is a PhD training program at The University of Western Australia (UWA) that provides transdisciplinary biomedical research training to early-stage PhD candidates. The program offers customised candidature milestones including a 12-month proposal deadline (versus the standard 6 months), BioZone Collaboration Grants to support multidisciplinary projects, and BioZone Completion Scholarships extending stipends to four years. It connects researchers from UWA's Schools of Engineering, Biological, Biomedical, Molecular and Human Sciences with industry, clinical, and academic networks to address complex local and global biomedical challenges.

Product overview

BioZone is not a product company; it is a collaborative PhD training program at the University of Western Australia (UWA) that brings together researchers from various disciplines (Engineering, Biological, Biomedical, Molecular, and Human Sciences) to foster transdisciplinary research and development in biomedical fields. The program offers PhD candidates access to world-class mentorship, collaborative grants, customized milestones, and industry/clinical engagement opportunities. Research focus areas include cancer, neurogenetic diseases, heart disease & stroke, kidney disease, and mental health. Featured research projects include FOCUST (Fluorescent Object and Cell gpU-accelerated Segmentation Toolbox), Novel Biomaterials, Soft Robotics, 3D Granular Hydrogels, Stem Cell Bioengineering, and rTMS research.

Differentiator

Problem solved

Functional benefit

Products and services

• BioZone PhD Training Program A transdisciplinary PhD training program for early-stage PhD candidates at The University of Western Australia, offering customised candidature milestones including a 12-month proposal deadline (versus the standard 6 months), world-class mentorship from leaders in the scientific and innovation community, and access to multidisciplinary research collaboration across engineering, biological, biomedical, molecular and human sciences. Targets early-stage PhD candidates seeking to address complex local and global biomedical challenges in cancer, neurogenetic diseases, heart disease and stroke, kidney disease, and mental health.
• BioZone Collaboration Grants Financial support grants provided to BioZone researchers to enable side-by-side work, sharing of ideas, expertise, and resources for novel multidisciplinary research projects. Grant applications require minimum two primary investigators with at least one BioZone candidate to qualify.
• BioZone Completion Scholarships Scholarships extending PhD candidate stipends to a full four years to support completion of transdisciplinary research. Two scholarships available annually, confirmed through 2026.

Quantifiable outcome

• Two BioZone Completion Scholarships available annually (confirmed through 2026)
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Twelve partnerships are on record, tiered core and minor.

• WA Life Sciences Innovation HubcoreStrategic or Co-development Partner · 24 September 2024Supported the 10th anniversary celebration event. Prof Kevin Pfleger serves as Director Biomedical and Health Innovation of the hub. Partnership facilitates translation of research into clinical practice.
• Perth BiodesigncoreStrategic or Co-development PartnerBioZone collaborates with Perth Biodesign on healthcare innovation initiatives. Prof Kevin Pfleger serves as Chair of Perth Biodesign and Biodesign Australia, linking the programs for mutual advancement of medical technology development.
• WA Biomedical Engineering SocietycoreStrategic or Co-development PartnerCollaborative partner for innovation events including the 10th anniversary celebration and joint Innovation in Medicine events. Partnership strengthens connection between biomedical engineering research community and BioZone researchers.
• Dimerix LimitedcoreStrategic or Co-development PartnerASX-listed clinical stage biotechnology company. Prof Kevin Pfleger serves as Chief Scientific Advisor and co-inventor of the company's Receptor-Heteromer Investigation Technology (HIT) platform.
• CoraMetix Pty LtdcoreStrategic or Co-development PartnerStart-up company co-founded by A/Prof Elena De-Juan-Pardo developing novel biopolymeric heart valve technology based on translational 3D printing research.
• RAGE BiotechminorStrategic or Co-development PartnerCompany co-founded by Prof Kevin Pfleger focused on advancing biotechnology innovations from academic research.
• VeinTechminorStrategic or Co-development PartnerProf Kevin Pfleger chairs the Advisory Board of this company, indicating collaborative engagement in vascular health innovation.
• Harry Perkins Institute of Medical ResearchcoreStrategic or Co-development PartnerPrimary research base for many BioZone researchers and students. Houses multiple BioZone labs including BRITElab, T3mPLATE laboratory, and Choi Lab.
• Perron Institute for Neurological and Translational SciencecoreStrategic or Co-development PartnerResearch institute where several BioZone alumni and students conduct research, particularly in neurological and motor neuron disease areas.
• TeleMedVetminorStrategic or Co-development PartnerCollaborative partnership mentioned in student research for in vivo application of paraspeckle research in racehorses.
• OrthocellminorStrategic or Co-development PartnerIndustrial partnership involved in alumni Behzad Shiroud Heidari's PhD research on biodegradable materials for tendon and ligament tissue engineering.
• CSIROminorStrategic or Co-development PartnerCSIRO industry PhD candidate Henry Purbrick conducts research linked with biopharmaceutical industry partner for drug discovery.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Translational Research Institute (TRI): Brisbane-based translational research institute combining biomedical, clinical, and industry researchers. Comparable to BioZone's focus on bridging biomedical research with industry and clinical translation in cancer, kidney, and other disease areas.
• Harry Perkins Institute of Medical Research: Perth-based medical research institute housing BRITElab, T3mPLATE and Choi Lab—directly used by BioZone researchers. Core operational peer and physical host for BioZone's wet-lab research, making it the closest functional peer.
• Australian Institute for Bioengineering and Nanotechnology (AIBN), UQ: UQ-based institute focused on bioengineering and nanotechnology research with industry partnerships and translational output. Comparable to BioZone's biomedical engineering and bio-fabrication research areas (e.g., soft robotics, 3D printing, biomaterials).
• Centenary Institute: University of Sydney-affiliated medical research institute focused on inflammation, cancer, and cardiovascular disease. Comparable to BioZone in disease-area coverage (cancer, cardiovascular) and the model of combining academic research with translational pipelines.
• Institute for Molecular Bioscience (IMB), The University of Queensland: UQ-based life sciences research institute combining biology, chemistry, and computational research with strong industry translation. Comparable to BioZone's transdisciplinary UWA-based biomedical research model and PhD training pipeline.
• SAHMRI (South Australian Health and Medical Research Institute): Adelaide-based flagship health and medical research institute with cross-disciplinary teams and a focus on translational outcomes. Comparable to BioZone's positioning as a state-anchored, multi-disease biomedical research engine with industry ties.
• EMBL Australia: Australian node of the European Molecular Biology Laboratory operating transdisciplinary life science research groups across multiple universities. Comparable to BioZone as a multi-university transdisciplinary biomedical training and research program with international anchoring.
• Bio21 Institute (University of Melbourne): University-based, multidisciplinary biomedical and translational research institute at the University of Melbourne. Highly comparable to BioZone as a cluster of UWA-aligned researchers working across biology, engineering, and medicine to translate research into health outcomes.

Broad incumbents

• Perth Biodesign: WA-based medtech innovation program (closely linked to BioZone via Prof Pfleger as Chair of Perth Biodesign and Biodesign Australia). Overlapping faculty and shared translation pathway make it a strategic adjacent program rather than a direct research peer.

Regional players

• Telethon Kids Institute: Perth-based child health research institute operating across paediatric and adolescent disease areas. Regionally co-located with BioZone in Western Australia and shares several faculty, but its focus on paediatric research differentiates it from BioZone's broader transdisciplinary scope.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/biozoneuwa

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioZone